1 Min Read
April 3 (Reuters) - Suven Life Sciences Ltd:
* PATENT CORRESPONDING TO NEW CHEMICAL ENTITY FOR TREATMENT OF DISORDERS ASSOCIATED WITH NEURODEGENERATIVE DISEASES
* PATENT IS VALID THROUGH 2033 Source text - bit.ly/2pZFzag Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.